Skip to main content
OpenTrials

Clinical trial condition

Leukemia, B-Cell

Explore clinical trials studying Leukemia, B-Cell. Study availability and eligibility vary by location and protocol.

1,389 public trials 159 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, B-Cell trial results

Completed

CHAIROS Study A Study of MabThera/Rituxan (Rituximab) Maintenance Therapy in Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Naive to Chemotherapy

NCT02013817

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
Locations
  • Tiroler Landeskrankenanstalten Ges.M.B.H.; Innere Medizin Abt. Für Hämatologie & Onkologie Innsbruck, Austria
  • LKH Hochsteiermark; Abt. für Innere Medizin Leoben, Austria
  • Kh Der Barmherzigen Schwestern; Interne I X Linz, Austria
  • A.Ö. Krankenhaus Der Elisabethinen Linz; I. Interne Abt. Linz, Austria
View Trial Details
Completed

A Study of MabThera (Rituximab) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia.

NCT00738374

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
Locations
  • Uni Degli Studi Di Bari, Policlinico; Cattedra Di Ematologia,Dipart. Di Medicina Interna E Publica Bari, Apulia, Italy
  • Az. Osp. Pugliese; Dh Oncologico Catanzaro, Calabria, Italy
  • P.O. Annunziata; U.O. Ematologia Cosenza, Calabria, Italy
  • Ospedale Riuniti; Divisione Di Ematologia Reggio Calabria, Calabria, Italy
View all 20 locations
View Trial Details
Completed

Bendamustine Hydrochloride (HCl) in Indolent Non-Hodgkin's Lymphoma That Has Progressed During or Following Treatment With a Rituximab Regimen or Previously Untreated Chronic Lymphocytic Leukemia

NCT01500083

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations
  • CA015 Calgary, Alberta, Canada
  • CA014 Edmonton, Alberta, Canada
  • CA016 Kelowna, British Columbia, Canada
  • CA011 Vancouver, British Columbia, Canada
View all 16 locations
View Trial Details
Completed

FCR Versus FC Alone in the Treatment of Chronic Lymphocytic Leukemia (CLL) in Relapsed Patients

NCT00090051

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Uab Comprehensive Cancer Center Birmingham, Alabama, United States
  • Pacific Coast Hematology/Oncology Medical Group Fountain Valley, California, United States
  • California Cancer Center Woodward Park; Community Medical Centers Fresno, California, United States
  • Rush-Presbyterian St. Luke'S Medical Center Chicago, Illinois, United States
View all 106 locations
View Trial Details
Completed

A Study to Determine Final Geriatric Assessment in Haematology (GAH) Score as a Tool for Predicting Tolerance to Treatment in Elderly Patients (≥ 65 Years) With Haematologic Neoplasms

NCT02842229

Conditions
Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +28 more
Locations
  • Hospital Germans Trias i Pujol Badalona, Barcelona, Spain
  • Hospital Durán I Reynals L'Hospitalet de Llobregat, Barcelona, Spain
  • Hospital Parc Taulí Sabadell, Barcelona, Spain
  • C.H. Universitario A Coruña A Coruña, La Coruña, Spain
View all 15 locations
View Trial Details

Related conditions